DK0773956T3 - Renset form for streptograminer, fremstilling deraf og farmaceutiske sammensætninger, der indeholder denne - Google Patents

Renset form for streptograminer, fremstilling deraf og farmaceutiske sammensætninger, der indeholder denne

Info

Publication number
DK0773956T3
DK0773956T3 DK95926996T DK95926996T DK0773956T3 DK 0773956 T3 DK0773956 T3 DK 0773956T3 DK 95926996 T DK95926996 T DK 95926996T DK 95926996 T DK95926996 T DK 95926996T DK 0773956 T3 DK0773956 T3 DK 0773956T3
Authority
DK
Denmark
Prior art keywords
alkyl
dialkylamino
alkylamino
halogen
ether
Prior art date
Application number
DK95926996T
Other languages
English (en)
Inventor
Denis Thibaut
Jean-Marc Paris
Pascal Anger
Jean-Claude Barriere
Bertrand Bonnavaud
Patrick Lefevre
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9465984&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0773956(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0773956T3 publication Critical patent/DK0773956T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95926996T 1994-08-02 1995-07-31 Renset form for streptograminer, fremstilling deraf og farmaceutiske sammensætninger, der indeholder denne DK0773956T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9409564A FR2723373B1 (fr) 1994-08-02 1994-08-02 Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR1995/001026 WO1996004298A1 (fr) 1994-08-02 1995-07-31 Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
DK0773956T3 true DK0773956T3 (da) 2001-09-24

Family

ID=9465984

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95926996T DK0773956T3 (da) 1994-08-02 1995-07-31 Renset form for streptograminer, fremstilling deraf og farmaceutiske sammensætninger, der indeholder denne

Country Status (13)

Country Link
US (1) US6384014B1 (da)
EP (1) EP0773956B1 (da)
JP (1) JPH10503511A (da)
AT (1) ATE202784T1 (da)
AU (1) AU3117495A (da)
CA (1) CA2196450A1 (da)
DE (1) DE69521615T2 (da)
DK (1) DK0773956T3 (da)
ES (1) ES2160171T3 (da)
FR (1) FR2723373B1 (da)
GR (1) GR3036173T3 (da)
PT (1) PT773956E (da)
WO (1) WO1996004298A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1624999A (en) * 1997-12-24 1999-07-19 Teresa J. Ingram Compositions comprising equisetum and symphytum and methods for the treatment of symptoms associated with mycoplasma infection
FR2775288B1 (fr) * 1998-02-26 2000-03-31 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositons qui les contiennent
FR2796950B1 (fr) * 1999-07-27 2001-09-21 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
ES2204681T3 (es) * 1999-07-27 2004-05-01 Aventis Pharma S.A. Derivados de estreptograminas, su preparacion y composiciones que los contienen.
BR0309398A (pt) 2002-04-19 2005-02-01 Cellular Genomics Inc Composto ou um seu sal, hidrato, solvato, forma cristalina, diastereÈmero, prodroga farmaceuticamente aceitável, ou misturas deles, composição farmacêutica, e, métodos para tratar uma condição envolvida com a cinase em um mamìfero, para tratar câncer, e para identificar uma cinase
US7312341B2 (en) 2002-09-09 2007-12-25 Cgi Pharmaceuticals, Inc. 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
WO2004072081A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
WO2005014599A1 (en) 2003-06-04 2005-02-17 Cellular Genomics, Inc. Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds
US7393848B2 (en) 2003-06-30 2008-07-01 Cgi Pharmaceuticals, Inc. Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
WO2005019220A2 (en) 2003-08-11 2005-03-03 Cellular Genomics Inc. Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
WO2007024294A2 (en) 2005-05-03 2007-03-01 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
US7776535B2 (en) 2006-02-06 2010-08-17 Franklin And Marshall College Site-specific incorporation of fluorinated amino acids into proteins
CA2714414A1 (en) 2008-02-13 2009-08-20 Cgi Pharmaceuticals, Inc. Certain substituted amides, method of making, and method of use thereof
CN102307581B (zh) 2008-12-08 2016-08-17 吉利德康涅狄格股份有限公司 咪唑并哌嗪syk抑制剂
MX2011006091A (es) 2008-12-08 2011-11-29 Gilead Connecticut Inc Inhibidores de imidazopirazina syk.
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
NZ602362A (en) 2010-03-11 2014-11-28 Gilead Connecticut Inc Imidazopyridines syk inhibitors
PL3027618T3 (pl) 2013-07-30 2021-04-19 Kronos Bio, Inc. Polimorf inhibitorów syk
KR20160036590A (ko) 2013-07-30 2016-04-04 질레드 코네티컷 인코포레이티드 Ｓｙｋ 억제제의 제제
US9687492B2 (en) 2013-12-04 2017-06-27 Gilead Sciences, Inc. Methods for treating cancers
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
TWI735853B (zh) 2013-12-23 2021-08-11 美商克洛諾斯生技有限公司 脾酪胺酸激酶抑制劑
EA201790086A1 (ru) 2014-07-14 2017-07-31 Джилид Сайэнс, Инк. Комбинации для лечения раковых заболеваний
US11384082B2 (en) 2017-08-25 2022-07-12 Kronos Bio, Inc. Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors
KR20210131372A (ko) 2019-02-22 2021-11-02 크로노스 바이오, 인코포레이티드 Syk 억제제로서의 축합된 피라진의 고체 형태

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549063B1 (fr) 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2549062B1 (fr) 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2619008B1 (fr) 1987-08-03 1990-06-29 Cird Utilisation de synergistines dans des compositions pharmaceutiques ou cosmetiques anti-acneiques
FR2674539B1 (fr) * 1991-03-28 1993-05-21 Rhone Poulenc Rorer Sa Procede de preparation enzymatique de macrolactone.
FR2696189B1 (fr) 1992-09-25 1994-11-10 Rhone Poulenc Rorer Sa Polypeptides impliqués dans la biosynthèse des streptogramines, séquences nucléotidiques codant pour ces polypeptides et leur utilisation.
IL121821A (en) 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
FR2701709B1 (fr) 1993-02-17 1995-04-07 Rhone Poulenc Rorer Sa Forme purifiée de streptograminés, sa préparation et les compositions pharmaceutiques qui la contiennent.

Also Published As

Publication number Publication date
EP0773956B1 (fr) 2001-07-04
AU3117495A (en) 1996-03-04
FR2723373B1 (fr) 1996-09-13
DE69521615D1 (de) 2001-08-09
FR2723373A1 (fr) 1996-02-09
JPH10503511A (ja) 1998-03-31
CA2196450A1 (fr) 1996-02-15
ES2160171T3 (es) 2001-11-01
PT773956E (pt) 2001-11-30
WO1996004298A1 (fr) 1996-02-15
GR3036173T3 (en) 2001-10-31
ATE202784T1 (de) 2001-07-15
EP0773956A1 (fr) 1997-05-21
US6384014B1 (en) 2002-05-07
DE69521615T2 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
DK0773956T3 (da) Renset form for streptograminer, fremstilling deraf og farmaceutiske sammensætninger, der indeholder denne
EP0578083A3 (da)
IL96507A0 (en) Nitrogen-containing spirocycles and pharmaceutical compositions containing them
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
IL105717A0 (en) 7beta substituted-4-aza-5alpha-cholestan-3-ones and pharmaceutical compositions containing them
ES8707733A1 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
IE812974L (en) Tri-,tetra- and penta peptides
DK0513675T3 (da) Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf
MX9300433A (es) Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.
ES2010853A6 (es) Composiciones de tensoactivos sinergicos.
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ZA944727B (en) Phosphonic acid compounds processes for preparing them and pharmaceutical compositions containing them
IL97148A0 (en) Oxetanones,their manufacture and pharmaceutical compositions containing them
PH20421A (en) Derivatives of piperidinedione for protecting the myocardium presenting an anti-arrythmic activity and pharmaceutical compositions containing them
TW252979B (da)
DK0578521T3 (da) Hidtil ukendt peptid-derivater med bradykininantagonistisk virkning, fremgangsmåde til fremstilling af derivaterne og farmaceutiske sammensætninger indeholdende disse
AU679132B2 (en) New eburnane analogues, a process for the preparation thereof and pharmaceutical compositions containing them
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
IL112099A0 (en) N-oxides of 4-arylpiperazines and 4-arylpiperidines and pharmaceutical compositions containing them
DE69623464D1 (de) Modifizierte kojibioside analoge
CO4761030A1 (es) Mezclas fungicidas que contienen al menos un compuesto seleccionado de carbamatos con grupos aromaticos y un carbamato alifatico
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
ES2001701A6 (es) Un metodo para preparar compuesto de benzoilurea
ES2103553T3 (es) Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AU1234588A (en) New acetamides derived from 2,3-dihydro-3-phenyl-2-benzofuranone, processes for preparing them and the pharmaceutical compositions which contain them